Diversified Trust’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,846
| Closed | -$810K | – | 907 |
|
|
2024
Q1 | $810K | Buy |
22,846
+6,208
| +37% | +$248K | 0.02% | 380 |
|
|
2023
Q4 | $725K | Buy |
16,638
+1,494
| +10% | +$58.8K | 0.02% | 387 |
|
|
2023
Q3 | $578K | Sell |
15,144
-6,783
| -31% | -$285K | 0.02% | 412 |
|
|
2023
Q2 | $902K | Sell |
21,927
-5,787
| -21% | -$279K | 0.03% | 306 |
|
|
2023
Q1 | $1.59M | Sell |
27,714
-183
| -0.7% | -$10.3K | 0.06% | 177 |
|
|
2022
Q4 | $1.56M | Sell |
27,897
-6,042
| -18% | -$308K | 0.07% | 164 |
|
|
2022
Q3 | $1.44M | Buy |
33,939
+4,903
| +17% | +$251K | 0.07% | 153 |
|
|
2022
Q2 | $1.57M | Hold |
29,036
| – | – | 0.07% | 148 |
|
|
2022
Q1 | $1.87M | Buy |
29,036
+2,425
| +9% | +$160K | 0.07% | 149 |
|
|
2021
Q4 | $1.78M | Hold |
26,611
| – | – | 0.06% | 163 |
|
|
2021
Q3 | $1.82M | Sell |
26,611
-1,209
| -4% | -$85.4K | 0.07% | 146 |
|
|
2021
Q2 | $1.9M | Sell |
27,820
-450
| -2% | -$31.8K | 0.07% | 139 |
|
|
2021
Q1 | $1.95M | Sell |
28,270
-90
| -0.3% | -$6.1K | 0.08% | 130 |
|
|
2020
Q4 | $1.84M | Buy |
28,360
+810
| +3% | +$43.6K | 0.07% | 127 |
|
|
2020
Q3 | $1.3M | Buy |
27,550
+1,245
| +5% | +$59.2K | 0.06% | 147 |
|
|
2020
Q2 | $1.24M | Buy |
26,305
+4,048
| +18% | +$199K | 0.06% | 130 |
|
|
2020
Q1 | $994K | Buy |
22,257
+2,190
| +11% | +$115K | 0.06% | 130 |
|
|
2019
Q4 | $1.17M | Buy |
20,067
+2,480
| +14% | +$148K | 0.05% | 128 |
|
|
2019
Q3 | $1.06M | Sell |
17,587
-1,035
| -6% | -$61.7K | 0.05% | 120 |
|
|
2019
Q2 | $1.04M | Buy |
18,622
+2,605
| +16% | +$134K | 0.05% | 130 |
|
|
2019
Q1 | $892K | Hold |
16,017
| – | – | 0.04% | 141 |
|
|
2018
Q4 | $722K | Buy |
16,017
+890
| +6% | +$48.8K | 0.04% | 147 |
|
|
2018
Q3 | $996K | Buy |
15,127
+220
| +1% | +$13.7K | 0.05% | 119 |
|
|
2018
Q2 | $960K | Buy |
14,907
+60
| +0.4% | +$3.71K | 0.06% | 110 |
|
|
2018
Q1 | $822K | Buy |
14,847
+1,530
| +11% | +$80.2K | 0.05% | 119 |
|
|
2017
Q4 | $637K | Buy |
13,317
+1,047
| +9% | +$51.2K | 0.04% | 140 |
|
|
2017
Q3 | $619K | Sell |
12,270
-680
| -5% | -$34.9K | 0.05% | 139 |
|
|
2017
Q2 | $706K | Sell |
12,950
-600
| -4% | -$28.7K | 0.06% | 137 |
|
|
2017
Q1 | $571K | Buy |
13,550
+350
| +3% | +$15K | 0.04% | 146 |
|
|
2016
Q4 | $566K | Buy |
13,200
+2,200
| +20% | +$89.4K | 0.05% | 134 |
|
|
2016
Q3 | $454K | Sell |
11,000
-4,000
| -27% | -$168K | 0.05% | 173 |
|
|
2016
Q2 | $598K | Buy |
15,000
+1,400
| +10% | +$50.4K | 0.07% | 219 |
|
|
2016
Q1 | $458K | Buy |
13,600
+2,000
| +17% | +$62.3K | 0.05% | 248 |
|
|
2015
Q4 | $393K | Sell |
11,600
-1,400
| -11% | -$43.8K | 0.04% | 286 |
|
|
2015
Q3 | $387K | Sell |
13,000
-2,168
| -14% | -$67.8K | 0.04% | 304 |
|
|
2015
Q2 | $418K | Sell |
15,168
-2,202
| -13% | -$58.7K | 0.04% | 322 |
|
|
2015
Q1 | $438K | Sell |
17,370
-2,446
| -12% | -$57.8K | 0.04% | 341 |
|
|
2014
Q4 | $439K | Buy |
+19,816
| New | +$402K | 0.04% | 344 |
|
|
2014
Q2 | $507K | Buy |
+26,349
| New | +$491K | 0.04% | 368 |
|
|
2013
Q4 | $648K | Hold |
33,211
| – | – | 0.07% | 271 |
|
|
2013
Q3 | $546K | Sell |
33,211
-2,507
| -7% | -$40.2K | 0.06% | 301 |
|
|
2013
Q2 | $535K | Buy |
+35,718
| New | +$523K | 0.06% | 287 |
|
Other funds holding IART
CB
Diversified Trust's IART Position: Q2 2024 in Review
Diversified Trust sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 22,846 shares — an estimated $810K sold.
Diversified Trust first reported a position in IART in Q2 2013 and held it in 42 quarters. The position peaked at $1.95M in Q1 2021. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.
- Diversified Trust reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
- Diversified Trust sold 22,846 Integra LifeSciences shares in Q2 2024, an estimated $810K.
- Diversified Trust first reported a position in Integra LifeSciences in Q2 2013 and held it in 42 quarters.
- Diversified Trust's Integra LifeSciences position peaked at $1.95M in Q1 2021.
- 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.
Based on Diversified Trust's 13F filing for Q2 2024, filed 16 Jul 2024.